High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors

  • Chem Biol. 2011 Jul 29;18(7):868-79. doi: 10.1016/j.chembiol.2011.05.010.
Chandrasekhar V Miduturu  1 ,  Xianming Deng ,  Nicholas Kwiatkowski ,  Wannian Yang ,  Laurent Brault ,  Panagis Filippakopoulos ,  Eunah Chung ,  Qingkai Yang ,  Juerg Schwaller ,  Stefan Knapp ,  Randall W King ,  Jiing-Dwan Lee ,  Sanna Herrgard ,  Patrick Zarrinkar ,  Nathanael S Gray
Affiliations
  • 1. Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Abstract

Selective protein kinase inhibitors have only been developed against a small number of kinase targets. Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compounds for established as well as unexplored kinase targets. We screened a library of 118 compounds constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 Kinases. A distinct kinase selectivity profile was observed for each scaffold. Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, Ack1, Mps1, PLK1-3, and Aurora A,B Kinases. In addition, we identified potent inhibitors for so far unexplored Kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation. This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.

Products